Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar
- Posted on February 4, 2026
- By CNBC
- 3 Views
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar
Eli Lilly's fourth-quarter earnings come as it tries to maintain its advantage over Novo Nordisk in the GLP-1 market.
